Ulrika Stierner - Concepedia

Author

Ulrika Stierner

Sahlgrenska University Hospital ORCID

Also Known As

Stierner, Ulrika, U STIERNER, U Stierner, U. K. Stierner, U. STIERNER, U. Stierner, Ulrika K. Stierner, Ulrika Stierner

104

Publications

Citations

H-Index

Concepts

All Affiliations

Sahlgrenska University Hospital University of Gothenburg Karolinska University Hospital Karolinska Institutet Lund University

About

Ulrika Stierner is an author at Sahlgrenska University Hospital specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	25	1.4K
2	Health Sciences	3	3	102
3	Education	1	1	75
4	Public Health	1	1	75
5	Allergy	1	1	70

Ulrika Stierner

Publications

3.9K

Citations

H-Index

Page 1

	Year	Citations
Risk-Adapted Treatment in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: The SWENOTECA Management Program Torgrim Tandstad, Olav Dahl, Gabriella Cohn‐Cedermark, Journal of Clinical Oncology	2009	262
Management of Seminomatous Testicular Cancer: A Binational Prospective Population-Based Study From the Swedish Norwegian Testicular Cancer Study Group Torgrim Tandstad, Rune Smaaland, Arne Solberg, Journal of Clinical Oncology	2011	230
An approach to suppress the evolution of resistance in BRAFV600E-mutant cancer Luciano G. Martelotto, Timour Baslan, Alberto Vides, Nature Medicine Systems BiologyMedicineTreatment ResistanceResistance Mutation (Virology)Brafv600e-mutant Cancer	2017	173
The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma Lars Ny, Henrik Jespersen, Joakim Karlsson, Nature Communications	2021	170
Molecular profiling of driver events in metastatic uveal melanoma Joakim Karlsson, Lisa M. Nilsson, Suman Mitra, Nature Communications	2020	162
One course of adjuvant BEP in clinical stage I nonseminoma mature and expanded results from the SWENOTECA group Torgrim Tandstad, O. Ståhl, Ulf Håkansson, Annals of Oncology Clinical StageMedicineImmunodeficienciesClinical TrialsPathology	2014	154
Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: a centre-based study of 17 patients Per Bümming, Jeanne M. Meis‐Kindblom, Hans Klingenstierna, British Journal of Cancer	2003	143
Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA) Torgrim Tandstad, O. Ståhl, O. Dahl, Annals of Oncology Risk-adapted RecommendationsAdjuvant CarboplatinUrologySurgical OncologyPatient Autonomy	2016	137
UVB Irradiation Induces Melanocyte Increase in Both Exposed and Shielded Human Skin Ulrika Stierner, Inger Rosdahl, A Augustsson, Journal of Investigative Dermatology Ultraviolet LightShielded Human SkinMelanomaPhotocarcinogenesisPhototoxicity	1989	118
Common and dysplastic naevi as risk factors for cutaneous malignant melanoma in a Swedish population. A Augustsson, Ulrika Stierner, Inger Rosdahl, Acta Dermato Venereologica Cutaneous Malignant MelanomaEpidemiologyMedicineMelanomaPathology	1991	117

Page 1